powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1912260829
John Schwerkoske
MD
Hematology-Oncology
Chula Vista,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
1,375
Beneficiaries
—
Total drug cost
$3.7M
Distinct drugs
44
Brand share
25.7%
Top prescribed drugs
Anastrozole
220 claims
Letrozole
113 claims
Alendronate Sodium
66 claims
Famotidine
54 claims
Ondansetron Hcl
51 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
102
Unique beneficiaries
—
Total services
238
Distinct HCPCS
4
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
167
By payment type
Food and Beverage
$4K
Long term medical supply or device loan
$382
Education
$129